在磁共振成像中加入肝胆期图像检测肝细胞癌的性能:一项荟萃分析
该荟萃分析纳入29项研究共2696个肝细胞癌病灶,评估在Gd-EOB-DTPA增强MRI中加入肝胆期图像对慢性肝病患者≤3 cm肝细胞癌的诊断性能。加入肝胆期后汇总敏感度为87%、特异度为92%、sROC曲线下面积为95%;加入肝胆期敏感度显著高于未加入(84% vs 68%,p=0.01),特异度相当。
要点
- 肝胆期低信号是诊断肝细胞癌的主要特征。
- 将廓清表现延伸至移行期或肝胆期可提高诊断敏感度且特异度相当。
- 加入肝胆期敏感度显著高于未加入(84% vs 68%,p=0.01)。
核心结论
- 在慢性肝病患者中,加入肝胆期的Gd-EOB-DTPA增强MRI诊断≤3 cm肝细胞癌的敏感度高于未加入肝胆期,特异度相当。
研究设计与样本
- 荟萃分析,检索多个数据库自建库至2020年4月10日,纳入29项研究共2696个肝细胞癌病灶,采用双变量随机效应模型计算汇总估计值。
关键影像表现/征象
- 肝胆期低信号是诊断肝细胞癌的主要特征。
- 加入肝胆期的诊断算法定义为动脉期高信号且门静脉期、延迟期或肝胆期中低信号的结节。
- 未加入肝胆期的诊断标准为动脉期强化且门静脉期或延迟期低信号的结节。
诊断标准与关键数值
- 加入肝胆期的Gd-EOB-DTPA增强MRI:汇总敏感度87%,特异度92%,sROC曲线下面积95%。
- 加入肝胆期 vs 未加入肝胆期的汇总敏感度:84% vs 68%(p=0.01),加入肝胆期显著更高。
- 加入肝胆期与未加入肝胆期的特异度相当。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the performance of diagnostic algorithm of adding hepatobiliary phase (HBP) images in Gd-EOB-DTPA-enhanced MRI for the detection of hepatocellular carcinoma (HCC) measuring up to 3 cm in patients with chronic liver disease.
METHODS: We searched multiple databases from inception to April 10, 2020, to identify studies on using Gd-EOB-DTPA-enhanced MRI for the diagnostic accuracy of HCC (≤ 3 cm) in patients with chronic liver disease. The diagnostic algorithm of Gd-EOB-DTPA-enhanced MRI with HBP for HCC was defined as a nodule showing hyperintensity during arterial phase and hypointensity during the portal venous, delayed, or hepatobiliary phases. For gadoxetic acid-enhanced MRI without HBP, the diagnostic criteria were a nodule showing arterial enhancement and hypointensity on the portal venous or delayed phases. The data were extracted to calculate summary estimates of sensitivity, specificity, diagnostic odds ratio, likelihood ratio, and summary receiver operating characteristic (sROC) by using a bivariate random-effects model.
RESULTS: Twenty-nine studies with 2696 HCC lesions were included. Overall Gd-EOB-DTPA-enhanced MRI with HBP had a sensitivity of 87%, specificity of 92%, and the area under the sROC curve of 95%. The summary sensitivity of Gd-EOB-DTPA-enhanced MRI with HBP was significantly higher than that without HBP (84% vs 68%, p = 0.01).
CONCLUSION: Gd-EOB-DTPA-enhanced MRI with HBP showed higher sensitivity than that without HBP and had comparable specificity for diagnosis of HCC in patients with chronic liver disease.
KEY POINTS: • Hypointensity on HBP is a major feature for diagnosis of HCC. • Extending washout appearance to the transitional or hepatobiliary phase on Gd-EOB-DTPA provides favorable sensitivity and comparable specificity for diagnosis HCC. • The summary sensitivity of gadoxetic acid-enhanced MRI with HBP was significantly higher than that without HBP (84% vs 68%, p = 0.01) for diagnosis of HCC in patients with chronic liver disease.
引用
- Pan, Li, Gu, et al. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis. Eur Radiol. 2022. PMID: 35579711. doi:10.1007/s00330-022-08826-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。